India

The Working Statement which patentees need to file every year continues to be a controversial subject. The frequent changes in the forms and varying stands of the patent office have added to the confusion.

印日関係は、6世紀の日本への仏教の普及から始まりました。1949年の第二次世界大戦後、インドのJawaharlal Nehru首相は東京の上野公園にインド象を一頭寄贈しています。1952年4月28日に両国は平和条約を締結して国交を開始します。この条約は第二次世界大戦後に日本が締結した最初の平和条約の一つです。 以来両国は互いに対する強固なサポートを育んで維持し、グローバルコミュニティにおける互いの立場を強化してきました。最近ではインドのNarendra Modi首相と日本の安倍晋三首相の主導の下、両国はそのつながりを強化し、 互いの重要性を認識しています。

Vikrant Rana of SS Rana analyses Japan and India’s close relationship in the field of IP, examining the Patent Prosecution Highway programme, the countries’ digital partnership and the establishment of a start-up hub

Invention has long been regarded as a mental activity that can only originate in human beings. However, with the booming of artificial intelligence (AI) technology in recent years, AI has been endowed with the ability to simulate human mental activities and perform innovative tasks by itself. So far, it is reported that AI technology is capable of conducting scientific experiments, developing technical crafts and completing industrial designs. In the near future, AI is even expected to have the capability to discover natural principles and create fundamental knowledge. Against this background, demands have risen for the protection of AI innovation. In particular, the question being asked is can those inventions solely made by AI "inventors" be protected through filing a patent application and be granted, just like those made by human beings?

In the fourth article from an exclusive series on the automotive industry, Bisman Kaur of Remfry & Sagar discusses brand value in India

Coronil, an ayurvedic drug (formulation of herbs and minerals) developed by Patanjali Ayurved that was initially promoted as a cure for the COVID-19 virus and later approved to be sold as an immunity booster to fight Coronavirus, has run into a controversy. A Chennai-based company Arudra Engineering (Arudra) filed a suit before the Madras High Court, alleging trademark infringement. Arudra sought an injunction restraining Patanjali Ayurved (Patanjali) and Divya Yog Mandir Trust, subsequently impleaded as a defendant, from using the mark "Coronil" or any deceptive variation.